+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Sinus Drug Stent System Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Biodegradable Sinus Drug Stent System Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Biodegradable Sinus Drug Stent System Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6080701
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The landscape of sinus care has entered a new era with the advent of biodegradable drug-eluting implant technologies designed to optimize postoperative recovery. These innovative stent systems combine targeted pharmaceutical delivery with materials that safely absorb over time, eliminating the need for removal procedures and reducing patient discomfort. By leveraging advanced polymers such as polylactic acid and polyglycolic acid, manufacturers have achieved controlled degradation profiles that maintain therapeutic drug release for the critical healing window. This executive summary distills the most pertinent developments and market dynamics surrounding this next-generation sinus treatment. It outlines the seismic shifts reshaping product pipelines, analyzes regulatory and economic headwinds, and highlights actionable insights drawn from comprehensive segmentation and regional analyses. As healthcare providers seek to enhance patient outcomes while managing costs, understanding these breakthroughs in design structure, drug release mechanism, and material composition becomes essential. This introduction sets the stage for an in-depth exploration of how evolving technologies, policy changes, and competitive strategies are converging to redefine standard of care in sinonasal intervention.

Transformative Shifts Reshaping Postoperative Sinus Care

Innovation in postoperative sinus management has accelerated as multidisciplinary research and clinical feedback converge on ever-more sophisticated approaches. Advances in polymer science have unlocked new avenues for hybrid materials that balance mechanical support with predictable absorption rates. Concurrently, drug-eluting stents now feature tailored release profiles-ranging from controlled to sustained delivery-addressing everything from chronic sinusitis to allergy-related inflammation. Minimally invasive implantation techniques, including refined endoscopic procedures, have further reduced patient morbidity and shortened recovery timelines. Regulatory bodies have responded by streamlining approval pathways for devices that demonstrate biocompatibility and clinical efficacy, spurring a wave of novel entrants into the space. Patient-centric design has also taken center stage, with pediatric-specific geometries and adult-focused high-strength formulations gaining traction. Moreover, sustainability considerations have prompted manufacturers to optimize material sourcing and minimize waste. Together, these transformative shifts are elevating clinical expectations and driving a strategic pivot toward solutions that not only deliver therapeutic payloads but also integrate seamlessly into evolving care pathways.

Cumulative Impact of 2025 U.S. Tariffs on Supply Chain Dynamics

The imposition of new U.S. tariffs in 2025 has had far-reaching consequences for the biodegradable sinus stent ecosystem. Suppliers of raw polymer materials-particularly those importing polylactic acid and polyglycolic acid-have encountered increased cost pressures that ripple through manufacturing and distribution channels. Device producers reliant on specialized hybrid blends have been compelled to reassess sourcing strategies, in some cases accelerating investments in domestic polymer synthesis to mitigate import surcharges. Consequently, procurement teams are negotiating more stringent supply agreements and exploring local production partnerships to secure critical components. The elevated input costs have also challenged margin structures, prompting price adjustments in some regions and driving manufacturers to seek operational efficiencies via automation and lean production methods. In addition, the tariff landscape has fueled dialogue around supply chain resilience, encouraging parallel shifts toward redundancy in logistics networks and alternative material formulations. As a result, stakeholders across the value chain are refocusing on strategic flexibility to withstand similar policy changes in the future.

Key Insights Across Multiple Market Segmentation Dimensions

A nuanced exploration of market segmentation reveals distinct opportunities and adoption patterns across multiple dimensions. When evaluating product variants, drug-eluting options dominate clinical trials while fully dissolvable designs gain favor among patients seeking minimal follow-up interventions, and partially dissolvable versions appeal to surgeons balancing support and absorption. Material composition insights show that polymer-based solutions are categorized by the choice between polyglycolic and polylactic acids-with the latter further divided into high molecular weight for extended support and low molecular weight for rapid absorption-while hybrid materials attract attention for their customizable performance attributes. Implantation techniques range from endoscopic procedures that prioritize outpatient convenience to minimally invasive and open surgery formats that accommodate complex anatomical cases. Therapeutic applications span allergy-related treatments, chronic sinusitis management, polyp excision support, and postoperative care protocols, each benefiting from specific drug release mechanisms-controlled, sustained, or targeted. Design structure preferences manifest in expandable frames for conformal cavity filling, mesh constructs for drainage facilitation, and plain tubes for simplicity. End-use settings stretch from hospitals and specialty clinics to research institutes and surgical centers, while patient demographics break down into adult, geriatric, and pediatric categories, the latter subdivided into children and infants to address age-specific device sizing and drug dosing considerations.

Key Regional Insights Across Americas, EMEA, and Asia-Pacific

Across the Americas, demand centers on procedure volumes in leading hospital networks and an uptick in outpatient therapy adoption. In Europe, emerging economies within Middle East and Africa present mixed regulatory landscapes that affect device registration timelines, whereas established Western markets focus on integrating new biodegradable platforms into standardized sinus care protocols. Meanwhile, Asia-Pacific demonstrates robust growth potential anchored by rising healthcare infrastructure investment, coupled with local manufacturers developing cost-competitive polymer blends. Shifts in reimbursement policies across these regions are influencing purchasing decisions, and cross-border collaborations are emerging to harmonize clinical data generation. From a market entry perspective, aligning product portfolios with regional procedural standards and regulatory frameworks will be critical for sustained expansion.

Competitive Landscape: Leading Industry Players and Innovations

The competitive environment features a diverse set of innovators, each advancing unique strengths. One group of companies is driving early-stage pipeline development with novel biodegradable formulations, while another cohort focuses on scaling production of established drug-eluting stents. Global medtech leaders leverage broad distribution networks to cross-sell sinus implants alongside other ENT products, whereas specialized firms concentrate on niche therapeutic applications and clinician training programs. Several players emphasize synergistic collaborations with academic centers to validate next-generation designs, and others prioritize strategic licensing to augment their material science portfolios. Across the board, companies are racing to differentiate through proprietary drug delivery mechanisms, advanced manufacturing certifications, and postmarket surveillance initiatives that underscore product safety and efficacy.

Actionable Recommendations for Leaders to Drive Market Success

Industry leaders can capitalize on momentum by adopting several strategic initiatives. First, prioritize R&D investment in high molecular weight polylactic acid formulations that deliver extended support while maintaining biocompatibility. Second, establish partnerships with domestic polymer producers to cushion against international tariff volatility and ensure supply chain continuity. Third, refine drug release mechanisms by leveraging microfabrication and nanocarrier technologies to achieve targeted delivery in polyp management and chronic sinusitis therapy. Fourth, expand clinical evidence generation through multicenter trials that validate device performance across diverse patient demographics, including pediatric subgroups. Fifth, enhance value propositions by integrating digital health tools-such as sensor-enabled stents-that track patient recovery metrics. Sixth, align regulatory engagement teams with evolving European and Asia-Pacific standards to accelerate market approvals. Finally, bolster end-use adoption by delivering specialized training modules to surgical centers and specialty clinics, thereby driving confidence in minimally invasive implantation techniques.

Conclusion: Strategic Implications and Future Trajectory

The convergence of advanced biomaterials, targeted drug delivery, and streamlined surgical approaches signals a pivotal juncture for sinus care. Stakeholders who embrace material innovation and adapt to geopolitical cost pressures will shape the trajectory of device adoption. Implementation of robust clinical programs and strategic alliances will foster credibility among key opinion leaders, while agile supply chain management will mitigate external disruptions. As the sector advances, continuous monitoring of therapeutic outcomes and regulatory shifts will underpin iterative product improvements. By synthesizing these insights and adopting a proactive stance, organizations can deliver patient-centric solutions that redefine standards of care and secure leadership positions in this rapidly evolving market.

Market Segmentation & Coverage

This research report categorizes the Biodegradable Sinus Drug Stent System Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Drug-Eluting
  • Fully Dissolvable
  • Non-Drug-Eluting
  • Partially Dissolvable
  • Hybrid Materials
  • Polymer-Based
    • Polyglycolic Acid
    • Polylactic Acid
      • High Molecular Weight
      • Low Molecular Weight
  • Endoscopic Procedure
  • Minimally Invasive
  • Open Surgery
  • Allergy-Related Treatment
  • Chronic Sinusitis
  • Polyp Management
  • Postoperative Care
  • Controlled Release
  • Sustained Release
  • Targeted Delivery
  • Expandable Frame
  • Mesh
  • Plain Tube
  • Hospitals
  • Research And Academic Institutes
  • Specialty Clinics
  • Surgical Centers
  • Adults
  • Geriatric
  • Pediatric
    • Children
    • Infants

This research report categorizes the Biodegradable Sinus Drug Stent System Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biodegradable Sinus Drug Stent System Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Acclarent, Inc.
  • Cook Medical LLC
  • Intersect ENT, Inc.
  • Lyra Therapeutics, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Olympus Corporation
  • SinuSys Corporation
  • Smith & Nephew plc
  • Stryker Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Sinus Drug Stent System Market, by Product Variants
8.1. Introduction
8.2. Drug-Eluting
8.3. Fully Dissolvable
8.4. Non-Drug-Eluting
8.5. Partially Dissolvable
9. Biodegradable Sinus Drug Stent System Market, by Material Composition
9.1. Introduction
9.2. Hybrid Materials
9.3. Polymer-Based
9.3.1. Polyglycolic Acid
9.3.2. Polylactic Acid
9.3.2.1. High Molecular Weight
9.3.2.2. Low Molecular Weight
10. Biodegradable Sinus Drug Stent System Market, by Implantation Technique
10.1. Introduction
10.2. Endoscopic Procedure
10.3. Minimally Invasive
10.4. Open Surgery
11. Biodegradable Sinus Drug Stent System Market, by Therapeutic Application
11.1. Introduction
11.2. Allergy-Related Treatment
11.3. Chronic Sinusitis
11.4. Polyp Management
11.5. Postoperative Care
12. Biodegradable Sinus Drug Stent System Market, by Drug Release Mechanism
12.1. Introduction
12.2. Controlled Release
12.3. Sustained Release
12.4. Targeted Delivery
13. Biodegradable Sinus Drug Stent System Market, by Design Structure
13.1. Introduction
13.2. Expandable Frame
13.3. Mesh
13.4. Plain Tube
14. Biodegradable Sinus Drug Stent System Market, by End-Use Setting
14.1. Introduction
14.2. Hospitals
14.3. Research And Academic Institutes
14.4. Specialty Clinics
14.5. Surgical Centers
15. Biodegradable Sinus Drug Stent System Market, by Patient Demographics
15.1. Introduction
15.2. Adults
15.3. Geriatric
15.4. Pediatric
15.4.1. Children
15.4.2. Infants
16. Americas Biodegradable Sinus Drug Stent System Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Biodegradable Sinus Drug Stent System Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Biodegradable Sinus Drug Stent System Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Acclarent, Inc.
19.3.2. Cook Medical LLC
19.3.3. Intersect ENT, Inc.
19.3.4. Lyra Therapeutics, Inc.
19.3.5. Medtronic plc
19.3.6. Meril Life Sciences Pvt. Ltd.
19.3.7. Olympus Corporation
19.3.8. SinuSys Corporation
19.3.9. Smith & Nephew plc
19.3.10. Stryker Corporation
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY FULLY DISSOLVABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY NON-DRUG-ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PARTIALLY DISSOLVABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY HYBRID MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ALLERGY-RELATED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHRONIC SINUSITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYP MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POSTOPERATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY EXPANDABLE FRAME, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MESH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PLAIN TUBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 90. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 140. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 141. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 142. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 143. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 144. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 145. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 147. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 148. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 149. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 150. CHINA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 151. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 152. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 153. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 154. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 155. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 156. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 158. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 159. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 160. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 161. INDIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 173. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 174. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 175. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 176. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 182. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 239. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 240. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 241. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 242. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY DESIGN STRUCTURE, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY END-USE SETTING, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY PRODUCT VARIANTS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 275. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYMER-BASED, 2018-2030 (USD MILLION)
TABLE 276. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY POLYLACTIC ACID, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY IMPLANTATION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BIODEGRADABLE SINUS DRUG STENT SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 201

Companies Mentioned

  • Acclarent, Inc.
  • Cook Medical LLC
  • Intersect ENT, Inc.
  • Lyra Therapeutics, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Olympus Corporation
  • SinuSys Corporation
  • Smith & Nephew plc
  • Stryker Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biodegradable Metal Vascular Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Biodegradable Metal Vascular Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global, United States Global, United States
From
Drug Eluting Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Drug Eluting Stent Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global, United States Global, United States
From
Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Coronary Stents Market Report 2025 - Product Image

Coronary Stents Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.